Kriti Nutrients Limited (KRITINUT) AI Stock Analysis

Kriti Nutrients Limited

(NSE:KRITINUT)

Select Model

Rating:67Neutral

Price Target:INR 68.00▲(2.80% Upside)

Action:downgraded

Date:10/29/26

The score is primarily supported by a conservative balance sheet and strong current cash generation. However, substantial profitability and margin deterioration, together with a bearish technical trend, materially constrain the outlook. The low P/E provides some valuation support, while the modest dividend yield offers limited additional benefit.

Positive Factors

Conservative balance sheetVery low leverage and steadily rising equity give Kriti Nutrients meaningful financial flexibility. The company is better positioned to withstand operating volatility, fund working-capital needs, and pursue growth without relying heavily on costly borrowing or taking material refinancing risk.

Negative Factors

Significant margin compressionThe substantial decline in gross and net margins shows that revenue growth is currently producing less profit. Persistent input-cost pressure or pricing constraints could limit earnings conversion, reduce returns on growth, and make future profits more sensitive to changes in the operating environment.

Kriti Nutrients Limited (KRITINUT) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 3.23B
Dividend Yield: 0.45%
Average Volume (3M): 2,549
Price to Earnings (P/E): 9.7
Beta (1Y): 1.74
Revenue Growth: 21.14%
EPS Growth: 3.47%
Country: India
Employees: 234
Sector: General
Sector Strength: 55
Industry: Packaged Foods

Kriti Nutrients Limited Business Overview & Revenue Model

Company Description

Kriti Nutrients Limited, established in 1992 and headquartered in Indore, India, operates in the manufacturing and global distribution of soybean seeds under its "Kriti" brand. The company's extensive product range includes various edible oils such a...

Kriti Nutrients Limited Financial Statement Overview

Summary

Strong balance-sheet quality and cash generation support the score: equity increased, debt declined to ₹91 million, debt-to-equity was 0.040, and operating cash flow rose 119%. These strengths are partly offset by significant margin compression and an 8.4% decline in net income despite revenue growth.

Income Statement

72Positive

Balance Sheet

78Positive

Cash Flow

75Positive

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	9.40B	9.22B	7.34B	6.83B	7.96B	7.51B
Gross Profit	753.15M	748.03M	1.03B	1.07B	780.37M	679.84M
EBITDA	482.00M	434.39M	557.89M	666.67M	356.28M	222.83M
Net Income	333.30M	339.01M	369.94M	452.87M	207.98M	123.05M
Balance Sheet
Total Assets	0	2.73B	2.38B	2.09B	1.93B	1.68B
Cash, Cash Equivalents and Short-Term Investments	492.76M	622.12M	265.85M	210.43M	190.38M	37.16M
Total Debt	0	91.01M	30.69M	121.45M	403.73M	375.58M
Total Liabilities	-2.29B	435.96M	259.39M	325.25M	607.00M	554.76M
Stockholders Equity	2.29B	2.29B	2.12B	1.76B	1.32B	1.13B
Cash Flow
Free Cash Flow	397.30M	642.82M	273.10M	409.62M	133.43M	-193.72M
Operating Cash Flow	427.15M	698.45M	319.58M	498.13M	198.61M	-105.10M
Investing Cash Flow	-321.63M	-152.65M	-288.64M	-291.87M	-31.35M	-199.81M
Financing Cash Flow	13.72M	-100.33M	-106.49M	-304.01M	-14.05M	311.86M

Kriti Nutrients Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price66.15

Price Trends

50DMA76.95Negative

100DMA79.14Negative

200DMA78.15Negative

Market Momentum

MACD-3.44Positive

RSI41.09Neutral

STOCH20.99Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Negative. The current price of 66.15 is below the 20-day moving average (MA) of 68.39, below the 50-day MA of 76.95, and below the 200-day MA of 78.15, indicating a bearish trend. The MACD of -3.44 indicates Positive momentum. The RSI at 41.09 is Neutral, neither overbought nor oversold. The STOCH value of 20.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KRITINUT.

Kriti Nutrients Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:KRITINUT against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:KRITINUT	67Neutral	INR 3.33B	9.70	―	0.45%	21.14%	3.47%
IN:GOKULAGRO	65Neutral	INR 63.44B	13.60	―	―	21.04%	59.07%
IN:GOKUL	59Neutral	INR 3.43B	16.39	―	―	15.39%	27.60%
IN:MUKKA	56Neutral	INR 7.38B	10.54	―	―	76.01%	59.13%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:ROML	54Neutral	INR 631.87M	13.57	―	―	20.89%	-11.15%
IN:MKPL	47Neutral	INR 1.48B	29.54	―	―	17.76%	-50.16%

* General Sector Average

Performance Comparison

IN:KRITINUT and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:KRITINUT	Kriti Nutrients Limited	66.45	-16.64	-20.03%
IN:GOKUL	Gokul Refoils & Solvent Ltd.	34.61	-6.39	-15.59%
IN:GOKULAGRO	Gokul Agro Resources Ltd.	215.00	47.30	28.21%
IN:MKPL	M K Proteins Limited	3.93	-2.80	-41.60%
IN:MUKKA	Mukka Proteins Limited	24.60	-0.47	-1.87%
IN:ROML	Raj Oil Mills Limited	39.52	-12.03	-23.34%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 29, 2026

Kriti Nutrients Limited AI Stock Analysis